PV-1 is recognized by the PAL-E antibody and forms complexes with NRP-1

Blood

Volumn 120, Issue 1, 2012, Pages 232-235

  Keuschnigg, Johannes ^a,b   Tvorogov, Denis ^c   Elima, Kati ^a,b   Salmi, Marko ^a,b   Alitalo, Kari ^c   Salminen, Tiina ^d   Jalkanen, Sirpa ^a,b  

^a UNIVERSITY OF TURKU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d ÅBO AKADEMI UNIVERSITY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; LEUKOCYTE ANTIBODY; NEUROPILIN 1; PATHOLOGISCHE ANATOMIE LEIDEN ENDOTHELIUM ANTIBODY; PLASMALEMMA VESICLE ASSOCIATED PROTEIN 1; PROTEIN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CELL LYSATE; CELL MEMBRANE; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LEUKOCYTE MIGRATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; STAINING; VASCULARIZATION;

EID: 84863586073     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-01-406876     Document Type: Article

References (24)

1. Schlingemann RO, Dingjan GM, Emeis JJ, Blok J, Warnaar SO, Ruiter DJ. Monoclonal antibody PAL-E specific for endothelium. Lab Invest. 1985;52(1):71-76. (Pubitemid 15157614)
2. Xu B, deWaal RM, Mor-Vaknin N, Hibbard C, Markovitz DM, Kahn ML. The endothelial cellspecific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol Cell Biol. 2004;24(20):9198-9206. (Pubitemid 39313921)
3. Niemelä H, Elima K, Henttinen T, Irjala H, Salmi M, Jalkanen S. Molecular identification of PAL-E, a widely used endothelial-cell marker. Blood. 2005;106(10):3405-3409. (Pubitemid 41609174)
4. Jaalouk DE, Ozawa MG, Sun J, et al. The original pathologische anatomie leiden-endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1. Cancer Res. 2007;67(20):9623-9629. (Pubitemid 47621207)
5. Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S. The prototype endothelial marker PAL-E is a leukocyte trafficking molecule. Blood. 2009;114(2):478-484.
6. Stan RV, Ghitescu L, Jacobson BS, Palade GE. Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol. 1999;145(6):1189-1198. (Pubitemid 29293631)
7. Fujisawa H, Kitsukawa T. Receptors for collapsin/ semaphorins. Curr Opin Neurobiol. 1998;8(5): 587-592.
8. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 1998;92(6):735-745. (Pubitemid 28155313)
9. Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem. 2002;85(2):357-368. (Pubitemid 34274903)
10. Cristea IM, Williams R, Chait BT, Rout MP. Fluorescent proteins as proteomic probes. Mol Cell Proteomics. 2005;4(12):1933-1941. (Pubitemid 41830187)
11. Carson-Walter EB, Hampton J, Shue E, et al. Plasmalemmal vesicle associated protein-1 is a novel marker implicated in brain tumor angiogenesis. Clin Cancer Res. 2005;11(21):7643-7650. (Pubitemid 41611605)
12. Schulz M, Engelhardt B. The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis. Cerebrospinal Fluid Res. 2005;2:8.
13. Lepelletier Y, Smaniotto S, Hadj-Slimane R, et al. Control of human thymocyte migration by Neuropilin-1/Semaphorin-3A-mediated interactions. Proc Natl Acad Sci U S A. 2007;104(13): 5545-5550. (Pubitemid 47175717)
14. Gu C, Rodriguez ER, Reimert DV, et al. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell. 2003;5(1):45-57. (Pubitemid 36827341)
15. Lee CC, Kreusch A, McMullan D, Ng K, Spraggon G. Crystal structure of the human neuropilin-1 b1 domain. Structure. 2003;11(1):99-108. (Pubitemid 36071497)
16. Giraudo E, Primo L, Audero E, et al. Tumor necrosis factor-alpha regulates expression of vascular endothelial growth factor receptor-2 and of its co-receptor neuropilin-1 in human vascular endothelial cells. J Biol Chem. 1998;273(34): 22128-22135. (Pubitemid 28405397)
17. Petrova TV, Makinen T, Alitalo K. Signaling via vascular endothelial growth factor receptors. Exp Cell Res. 1999;253(1):117-130.
18. Teesalu T, Sugahara KN, Kotamraju VR, Ruoslahti E. C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration. Proc Natl Acad Sci U S A. 2009; 106(38):16157-16162.
19. Dvorak AM, Feng D. The vesiculo-vacuolar organelle (VVO): a new endothelial cell permeability organelle. J Histochem Cytochem. 2001;49(4): 419-432.
20. Stan RV. Endothelial stomatal and fenestral diaphragms in normal vessels and angiogenesis. J Cell Mol Med. 2007;11(4):621-643. (Pubitemid 47313310)
21. Feng D, Nagy JA, Pyne K, Dvorak HF, Dvorak AM. Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med. 1998;187(6):903-915. (Pubitemid 28141664)
22. Strickland LA, Jubb AM, Hongo JA, et al. Plasmalemmal vesicle-associated protein (PLVAP) is expressed by tumour endothelium and is upregulated by vascular endothelial growth factor-A (VEGF). J Pathol. 2005;206(4):466-475. (Pubitemid 41025350)
23. Hnasko R, Carter JM, Medina F, Frank PG, Lisanti MP. PV-1 labels trans-cellular openings in mouse endothelial cells and is negatively regulated by VEGF. Cell Cycle. 2006;5(17):2021-2028. (Pubitemid 44435310)
24. Jia H, Cheng L, Tickner M, Bagherzadeh A, Selwood D, Zachary I. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity. Br J Cancer. 2010; 102(3):541-552.